Related references
Note: Only part of the references are listed.Influence of Cardiometabolic Risk Factors on Platelet Function
Cristina Barale et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Comparison of nine platelet function tests used to determine responses to different aspirin dosages in people with type 2 diabetes
Paul Harrison et al.
PLATELETS (2019)
Aspirin resistance mediated by oxidative stress-induced 8-Isoprostaglandin F2
Juan Guo et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2019)
Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases
Maria Angela Incalza et al.
VASCULAR PHARMACOLOGY (2018)
Simvastatin Effects on Inflammation and Platelet Activation Markers in Hypercholesterolemia
Cristina Barale et al.
BIOMED RESEARCH INTERNATIONAL (2018)
CD40L controls obesity-associated vascular inflammation, oxidative stress, and endothelial dysfunction in high fat diet-treated and db/db mice
Sebastian Steven et al.
CARDIOVASCULAR RESEARCH (2018)
Markers of Antioxidant Defense in Patients with Type 2 Diabetes
K. Gawlik et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes
Kamel Mohammedi et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus
Francesca Santilli et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
LDL oxidation by platelets propagates platelet activation via an oxidative stress-mediated mechanism
Roberto Carnevale et al.
ATHEROSCLEROSIS (2014)
Reactive metabolites and antioxidant gene polymorphisms in Type 2 diabetes mellitus
Monisha Banerjee et al.
REDOX BIOLOGY (2014)
High Glucose Inhibits the Aspirin-Induced Activation of the Nitric Oxide/cGMP/cGMP-Dependent Protein Kinase Pathway and Does Not Affect the Aspirin-Induced Inhibition of Thromboxane Synthesis in Human Platelets
Isabella Russo et al.
DIABETES (2012)
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes
B. Rocca et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Glutathione Peroxidase-3 Deficiency Promotes Platelet-Dependent Thrombosis In Vivo
Richard C. Jin et al.
CIRCULATION (2011)
Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome
Jose Luis Ferreiro et al.
CIRCULATION (2011)
Postprandial Blood Glucose Predicts Cardiovascular Events and All-Cause Mortality in Type 2 Diabetes in a 14-Year Follow-Up
Franco Cavalot et al.
DIABETES CARE (2011)
Age-related changes in an antioxidant defense system in elderly patients with essential hypertension compared with healthy controls
Joanna Rybka et al.
REDOX REPORT (2011)
Usefulness of Elevations in Serum Choline and Free F2-soprostane to Predict 30-Day Cardiovascular Outcomes in Patients With Acute Coronary Syndrome
Rebecca M. LeLeiko et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Atherogenesis and atherothrombosis - focus on diabetes mellitus
Bernd Stratmann et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Soluble Forms of RAGE in Human Diseases: Clinical and Therapeutical Implications
Francesca Santilli et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
LANCET (2009)
Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid Determinants and Effect on Cardiovascular Risk
John W. Eikelboom et al.
CIRCULATION (2008)
Resistance to Aspirin and Thienopyridines in Diabetes Mellitus and Metabolic Syndrome
Giovanni Anfossi et al.
CURRENT VASCULAR PHARMACOLOGY (2008)
Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents
Arun Natarajan et al.
DIABETES & VASCULAR DISEASE RESEARCH (2008)
Aspirin resistance and diabetes mellitus
R. Ajjan et al.
DIABETOLOGIA (2008)
Rebuttal to Aspirin response variability assessed with the PFA-100 device by Reny et al.
Marilena Crescente et al.
THROMBOSIS AND HAEMOSTASIS (2008)
High levels of low-density lipoprotein cholesterol and triglycerides and suboptimal glycemic control predict diminished ex vivo aspirin responsiveness in patients with Type 2 diabetes
M. M. C. Hovens et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes
Carlos Lorenzo et al.
DIABETES CARE (2007)
Drug insight: Aspirin resistance - fact or fashion?
Carlo Patrono et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2007)
Free radicals and antioxidants in normal physiological functions and human disease
Marian Valko et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Aspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX) 1/2, a novel COX-1 polymorphism or the PlA1/2 polymorphism
Roger Kranzhofer et al.
PLATELETS (2006)
Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic Hyperglycemia in patients with type 2 diabetes
L Monnier et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
A new definition of aspirin non-responsiveness by Platelet Function Analyzer-100™ and its predictors
A Abaci et al.
PLATELETS (2006)
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus
F Santilli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease
AO Maree et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Recent advances in the biochemistry and clinical relevance of the isoprostane pathway
ES Musiek et al.
LIPIDS (2005)
The pathobiology of diabetic complications - A unifying mechanism
M Brownlee
DIABETES (2005)
Screening for aspirin responsiveness after transient ischemic attack and stroke - Comparison of 2 point-of-care platelet function tests with optical aggregometry
P Harrison et al.
STROKE (2005)
Isoprostanes: Novel bioactive products of lipid peroxidation
S Basu
FREE RADICAL RESEARCH (2004)
Platelet activation in type 2 diabetes mellitus
P Ferroni et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Oxidative stress and antioxidant status in elderly diabetes mellitus and glucose intolerance patients
T Atli et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2004)
Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type 1 diabetes and early microangiopathy
F Chiarelli et al.
PEDIATRIC RESEARCH (2004)
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus -: Role of interleukin-6 and disease duration
G Davì et al.
CIRCULATION (2003)
Low-density lipoprotein and its effect on human blood platelets
IAM Relou et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2003)
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with Type II diabetes mellitus
P Gresele et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Platelet responsiveness to aspirin in patients with hyperlipidaemia
M Friend et al.
BRITISH MEDICAL JOURNAL (2003)
Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: Results of the Primary Prevention Project (PPP) trial
M Sacco et al.
DIABETES CARE (2003)
Platelet activation in obese women -: Role of inflammation and oxidant stress
G Davì et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events
JW Eikelboom et al.
CIRCULATION (2002)
Profile and prevalence of aspirin resistance in patients with cardiovascular disease
PA Gum et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome
PA Sakkinen et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2000)
Share Paper
